The COVID-19 pandemic highlighted the problems in vaccine access and research, with some nations receiving the vaccine 18 months after others.    

GoI is working with two leading non-profits in the world to bring G-20 member states together and agree upon a proposed Global Vaccine Research Collaborative.         

Mansukh Mandaviya, the health minister, remarked during the 3rd G-20 Health Working Group Meeting that G-20 may act as a forum for international collaboration between governments, research organisations, pharmaceuticals, and other stakeholders.          

The Global Vaccine Research Collaborative is being proposed to address gaps, enable equitable vaccine access, optimise resources, improve preparedness and foster an environment for vaccine research.         

The GoI has shortened regulatory processes and provided financial incentives to encourage vaccine companies to increase supply and has taken steps to ensure that vaccines are available in remote places by utilising PHCs and other healthcare facilities.